New York: Palm Inc has launched its smallest smartphone, making its initial entry into the low end phone market in a bid to perk up growth plans, and provide a cheesier option to Apple Inc’s iPhone.

For its new “Centro,” a smaller and lighter edition of its Treo smartphone, Palm has determined the price of just $100 to attract more and more customers. Sprint Nextel Corp will sell ‘Centro’ for the rest of the year in the United States.

According to a DeCA news release, the Defense Commissary Agency has called back a few of its frozen ground beef products accompanying a U.S. Department of Agriculture notice of possible E. coli contamination.

The group carries two of the recalled products prepared by Topps Meat Company LLC:

Washington, Sept.28 : A small space capsule has been lost in Earth orbit after a space tether experiment went awry on Tuesday.

Washington, Sept.28 : A national public opinion survey conducted by the Woods Institute for the Environment at Stanford University and the Associated Press has concluded that a majority of Americans continue to remain pessimistic about the environment and desire prompt action taken to improve its health.

Washington, Sept 28 : A new study has found that there is no difference in the risk of developing breast cancer between wine, beer or spirits, since it is the consumption of alcohol itself and the quantity that triggers the cancer.

The study found that the increased breast cancer risk from drinking three or more alcoholic drinks a day is similar to the increased breast cancer risk from smoking a packet of cigarettes or more a day.

Washington, Sept 28 : An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.

Dr. Sharmila Makhija, an associate professor in the Division of Gynecologic Oncology at the university, said that Phase II clinical trial data showed that pertuzumab added weeks to the lives of Stage III ovarian cancer patients, whose disease had returned after treatment with the existing chemotherapy regimens.